Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2018)
Supernus Pharmaceuticals (SUPN) posted quarterly Other financing activities of $65.7 million for Q1 2018, up 226410.34% on a QoQ basis from $29000.0 in Q3 2013.
Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2018) Analysis & Trends
Supernus Pharmaceuticals has reported Other financing activities for 4 years, with the latest figure at $65.7 million in Q1 2018.
- Other financing activities for Q1 2018 came in at $65.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $65.7 million (changed N/A YoY), and the FY2018 annual result was $65.7 million, changed N/A from the prior year.
- Other financing activities climbed to $65.7 million in Q1 2018, from $29000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $65.7 million in Q1 2018 and troughed at $65.7 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 65.69 Mn |
| Mar 31, 2018 | 65.69 Mn |
| Sep 30, 2013 | 29,000.00 |
| Sep 30, 2013 | 29,000.00 |
| Jun 30, 2013 | 3.47 Mn |
| Jun 30, 2013 | 3.47 Mn |
| Mar 31, 2013 | 125,000.00 |
| Mar 31, 2013 | 125,000.00 |
| Dec 31, 2012 | 3.16 Mn |
| Dec 31, 2012 | 3.16 Mn |
| Sep 30, 2012 | 16,000.00 |
| Sep 30, 2012 | 16,000.00 |
| Jun 30, 2012 | 2.20 Mn |
| Jun 30, 2012 | 2.20 Mn |
| Mar 31, 2012 | 669,000.00 |
| Mar 31, 2012 | 669,000.00 |
| Dec 31, 2011 | 129,000.00 |
| Dec 31, 2011 | 129,000.00 |
| Sep 30, 2011 | -2.77 Mn |
| Sep 30, 2011 | -2.77 Mn |